Avanos Medical (AVNS) EPS (Diluted) Growth (1y) (2014 - 2024)
Avanos Medical (AVNS) EPS (Diluted) Growth (1y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.96% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -23.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39.22% |
| Sep 30, 2024 | -131.51% |
| Jun 30, 2024 | 96.04% |
| Mar 31, 2024 | -119.38% |
| Dec 31, 2023 | -107.05% |
| Sep 30, 2023 | 8.97% |
| Jun 30, 2023 | -942.74% |
| Mar 31, 2023 | 36.90% |
| Dec 31, 2022 | 128.79% |
| Sep 30, 2022 | 113.63% |
| Jun 30, 2022 | -79.58% |
| Mar 31, 2022 | 164.55% |
| Dec 31, 2021 | 48.41% |
| Sep 30, 2021 | -282.90% |
| Jun 30, 2021 | 1,362.21% |
| Mar 31, 2021 | -327.03% |
| Dec 31, 2018 | -98.25% |
| Jun 30, 2018 | 17.07% |
| Mar 31, 2018 | 14.93% |
| Dec 31, 2017 | 125.22% |